Europe (WHO region) vs Kuwait: Previously treated cases tested for RR-/MDR-TB
Europe (WHO region)
90.0%
in 2024
Kuwait
100.0%
in 2016
Europe (WHO region) rank
2nd
Kuwait rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Europe (WHO region)
- Kuwait
How they compare
Kuwait currently reports 100.0% against 90.0% in Europe (WHO region), a difference of 10.0%.
That makes Kuwait's figure about 1.1 times Europe (WHO region)'s.
The two have swapped places 2 times across 7 shared years of data; in 2005 it was Kuwait ahead.
Europe (WHO region) ranks 2nd and Kuwait ranks 1st of 11 groups.
Kuwait has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Europe (WHO region) | Kuwait | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20.3% | 100.0% | 79.7% | Kuwait |
| 2010s | 52.3% | 66.7% | 14.3% | Kuwait |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Europe (WHO region) or Kuwait?
- Kuwait, at 100.0% against 90.0% in Europe (WHO region) as of 2016.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Europe (WHO region) and Kuwait?
- 10.0%, with Kuwait ahead.
- How many years of comparable data are there for Europe (WHO region) and Kuwait?
- 7 years are reported by both, from 2005 to 2016.
- How do Europe (WHO region) and Kuwait rank globally for previously treated cases tested for rr-/mdr-tb?
- Europe (WHO region) ranks 2nd and Kuwait ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.